Abstract
What drives the progression of neurodegenerative diseases like ALS, Alzheimer’s, and MS? Unraveling the mechanisms of neuroinflammation is at the heart of Prof. Bob Harris’s research at the Karolinska Institutet. His team is pioneering new therapeutic approaches by targeting microglial activity and harnessing advanced stem cell techniques. Their goal is to transform treatment strategies for these debilitating conditions.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call